False advertising
Metformin class action lawsuit
Metformin is a defendant in IN RE METFORMIN MARKETING AND SALES PRACTICES LITIGATION, a proposed class action filed on March 3, 2020 in District Court, D. New Jersey.
The court record lists the nature of suit as Other Fraud, on docket 2:20-cv-02324.
Case details
- Case
- IN RE METFORMIN MARKETING AND SALES PRACTICES LITIGATION
- Court
- District Court, D. New Jersey
- Docket number
- 2:20-cv-02324
- Case filed
- March 3, 2020
- Nature of suit
- Other Fraud
What this case is about
This case concerns allegations of fraud involving the marketing and sale of metformin. The provided docket information does not specify the particular marketing conduct or the defendant involved.
This summary describes the court filings listed below. It is not legal advice, and it does not establish whether you are a member of any class. That is set by the court-approved class definition.
How to check the official record
The full docket is public. If a settlement is approved, the court-appointed administrator, not Sparrow, publishes the claim form, the eligibility criteria, and the filing deadline.
View the docket on CourtListenerFind settlements you can file today
Sparrow tracks class action settlements that are open for claims and fills out the paperwork for you.
Browse open settlementsSparrow is a class action discovery platform, not a law firm, and is unaffiliated with any parties to this case. Case information is drawn from the public court record via CourtListener and may not reflect the most recent filings.